Publications by authors named "Laura Forgione"

Claim this Profile
L
Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical Diagnostics.
Cristin Roma, Alessandra Sacco, Laura Forgione, Riziero Esposito Abate, Matilde Lambiase

Diagnostics (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy.
Marianeve Carotenuto, Alessandra Sacco, Laura Forgione, Nicola Normanno

Explor Target Antitumor Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies.
Anna Maria Rachiglio, Laura Forgione, Raffaella Pasquale, Carlo Antonio Barone, Evaristo Maiello

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA Testing Opens New Perspectives in Melanoma Management.
Alessandra Sacco, Laura Forgione, Marianeve Carotenuto, Antonella De Luca, Paolo A Ascierto

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colorectal cancer genomic biomarkers in the clinical management of patients with metastatic colorectal carcinoma.
Anna Maria Rachiglio, Alessandra Sacco, Laura Forgione, Claudia Esposito, Nicoletta Chicchinelli

Explor Target Antitumor Ther· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted sequencing analysis of cell-free DNA from metastatic non-small-cell lung cancer patients: clinical and biological implications.
Raffaella Pasquale, Laura Forgione, Cristin Roma, Francesca Fenizia, Francesca Bergantino

Transl Lung Cancer Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of circulating free DNA in the management of NSCLC.
Riziero Esposito Abate, Raffaella Pasquale, Francesca Fenizia, Anna Maria Rachiglio, Cristin Roma, Laura Forgione

Expert Rev Anticancer Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer.
Marianna Gallo, Antonella De Luca, Monica Rosaria Maiello, Amelia D'Alessio, Claudia Esposito, Laura Forgione

Transl Lung Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients.
Raffaella Pasquale, Francesca Fenizia, Riziero Esposito Abate, Alessandra Sacco, Claudia Esposito, Laura Forgione

Pharmacogenomics· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR mutations in lung cancer: from tissue testing to liquid biopsy.
Francesca Fenizia, Antonella De Luca, Raffaella Pasquale, Alessandra Sacco, Laura Forgione

Future Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies.
Claudia Esposito, Anna Maria Rachiglio, Maria Libera La Porta, Alessandra Sacco, Cristin Roma, Laura Forgione

Cancer Biol Ther· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis